|
|
||||||||||
Registrar, Department of Endocrinology, Auckland Hospital, Auckland, New Zealand
Senior Lecturer in Medicine, Department of Medicine, University of Auckland; Physician, Department of Internal Medicine, Auckland Hospital
Associate Professor of Infectious Diseases, Department of Molecular Medicine and Pathology, University of Auckland; Physician, Department of Infectious Diseases, Auckland Hospital
Lecturer in Medicine, Department of Medicine, University of Auckland; Physician, Department of Internal Medicine, Auckland Hospital; Research Fellow in Bone Disease, Department of Medicine, University of Auckland
Senior Pharmacist, Pharmacy Department, Auckland Hospital
Associate Professor of Medicine and Clinical Pharmacology, Department of Medicine, University of Auckland; Physician, Department of Internal Medicine, Auckland Hospital
Reprints: Mark J Bolland MBChB, Department of Endocrinology, Auckland Hospital, Private Bag 92-024, Auckland 1, New Zealand, fax 64 9 3074993, mbolland{at}adhb.govt.nz
OBJECTIVE: To report a case of an interaction between inhaled corticosteroids and itraconazole causing iatrogenic Cushing's syndrome and provide a review of the relevant literature.
CASE SUMMARY: A 70-year-old white woman on long-term treatment with high-dose inhaled corticosteroids for asthma was diagnosed as having Scedosporium apiospermum infection of the skin and subcutaneous tissues. As a result, she was treated with itraconazole for 2 months. She subsequently developed Cushing's syndrome due to a probable cytochrome P450-mediated interaction between itraconazole and budesonide. She also had secondary adrenal insufficiency requiring prolonged treatment with replacement hydrocortisone.
DISCUSSION: Budesonide is a potent glucocorticoid that is metabolized in the liver by the CYP3A4 isoenzyme to inactive metabolites. Itraconazole is a potent cytochrome P450 inhibitor. It can inhibit the metabolism of oral or inhaled corticosteroids, producing cortisol excess leading to Cushing's syndrome and adrenal insufficiency. An assessment of causality indicated a possible adverse interaction between itraconazole and budesonide.
CONCLUSIONS: The combination of itraconazole and inhaled corticosteroids is increasingly being used to treat conditions such as allergic bronchopulmonary aspergillosis. Clinicians need to be aware of the potential for an interaction between such a combination.
Key Words: budesonide, Cushing's syndrome, itraconazole
Published Online, December 5, 2003. www.theannals.com, DOI 10.1345/aph.1D222
This article has been cited by other articles:
![]() |
N. Valin, N. De Castro, V. Garrait, A. Bergeron, C. Bouche, and J. M. Molina Iatrogenic Cushing's Syndrome in HIV-Infected Patients Receiving Ritonavir and Inhaled Fluticasone: Description of 4 New Cases and Review of the Literature J Int Assoc Physicians AIDS Care (Chic Ill), March 1, 2009; 8(2): 113 - 121. [Abstract] [PDF] |
||||
![]() |
H W. Kelly Comparison of Inhaled Corticosteroids: An Update Ann. Pharmacother., March 1, 2009; 43(3): 519 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Cortez, E. Roilides, F. Quiroz-Telles, J. Meletiadis, C. Antachopoulos, T. Knudsen, W. Buchanan, J. Milanovich, D. A. Sutton, A. Fothergill, et al. Infections Caused by Scedosporium spp. Clin. Microbiol. Rev., January 1, 2008; 21(1): 157 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
D R Woods, C S Arun, P A Corris, and P Perros Cushing's syndrome without excess cortisol. BMJ, February 25, 2006; 332(7539): 469 - 470. [Full Text] [PDF] |
||||